Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588861 · ClinicalTrials.gov registry record · NA
Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement
A NA study, sponsored by Biomet Orthopedics.
- Terminated
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT00588861 is a NA study that was terminated before completion, run by Biomet Orthopedics. The registered enrollment target is 400 participants.
The verdict
NCT00588861, a NA study, was terminated before completion, sponsored by Biomet Orthopedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to document the clinical outcomes of several devices used in total hip replacement, including the Answer® hip stem, the Ranawat/Burnstein® acetabular shell, and Simplex® or Palacos® bone cement.
Interventions
- DEVICE Answer® hip stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2002-09 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588861
The ClinicalTrials.gov registry entry for NCT00588861 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomet Orthopedics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Answer® hip stem is the first listed.
NCT00588861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588861 about?
NCT00588861 is a clinical study titled "Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement". The purpose of this study is to document the clinical outcomes of several devices used in total hip replacement, including the Answer® hip stem, the Ranawat/Burnstein® acetabular shell, and Simplex® or Palacos® bone cement.
What is the current status of trial NCT00588861?
This trial is currently terminated. It is a NA study. The enrollment target is 400 participants. The study started on 2002-09. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00588861?
The interventions under investigation include: Answer® hip stem (DEVICE).
Who is sponsoring clinical trial NCT00588861?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.